However, new discoveries about KRAS biology and its impact in the tumor microenvironment, together with the advent of immunotherapies and targeted therapies, may result in the development of effective treatment strategies and optimal therapeutic stratification of KRAS-mutant LA (25). Here, KRAS is linked to neoplasm.